PharmStockPharmacy Stock

Lopid
Lopid

1.68
A generic medicine indicated for cholesterol management. Reduces triglyceride levels by acting on lipid metabolism pathways in the digestive tract.
Ingredient
Gemfibrozil
Category
Cholesterol Management
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Gemfibrozil
Reference Brand
Gemfibrozil
Product Origin
Generic Alternative
Reference Manufacturer
Pfizer
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Cholesterol
Product Category
Fibric Acid Derivative
Pharmacological Class
Fibrate
Manufacturer Description
Designed to support triglyceride reduction to manage cardiovascular disease risk and alleviate vascular lipid accumulation.
Mechanism of Action
Stimulates peroxisome proliferator-activated receptor-alpha, increasing lipolysis and clearing VLDL from blood circulation.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
12 hours
Contraindications
Severe renal or hepatic impairment, Gallbladder disease, Concurrent repaglinide or simvastatin use
Severe Adverse Events
Rhabdomyolysis — requires immediate medical attention, Pancreatitis — requires immediate medical attention
Common Side Effects
Indigestion, Nausea, Abdominal pain
Uncommon Side Effects
Headache, Fatigue, Gallstones
Drug Interactions
Simvastatin, Repaglinide, Warfarin
Pregnancy Safety Warnings
TGA Category C: Use if potential benefits exceed risks. Breastfeeding: Avoid.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Tricor
Information related to Lopid is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to buy Hormone Medication Australia - Fludrocortisone Adrenal Insufficiency Steroid